Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding human biomonitoring

Christopher J Borgert1

  • 1Applied Pharmacology and Toxicology, Inc., Gainesville, FL 32605, USA. cjborgert@apt-pharmatox.com

Regulatory Toxicology and Pharmacology : RTP
|November 16, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypothesis-driven weight of evidence evaluation indicates ethylbenzene lacks endocrine disruption potential by EATS pathways.

EXCLI journal·2025
Same author

Octamethylcyclotetrasiloxane (D4) lacks endocrine disruptive potential via estrogen pathways.

Archives of toxicology·2025
Same author

Kinetically-derived maximal dose (KMD) confirms lack of human relevance for high-dose effects of octamethylcyclotetrasiloxane (D4).

Archives of toxicology·2025
Same author

The physiological and biochemical basis of potency thresholds modeled using human estrogen receptor alpha: implications for identifying endocrine disruptors.

Archives of toxicology·2024
Same author

Kinetically-derived maximal dose (KMD) indicates lack of human carcinogenicity of ethylbenzene.

Archives of toxicology·2023
Same author

Issue analysis: key characteristics approach for identifying endocrine disruptors.

Archives of toxicology·2023